Zvi is a myeloma patient and an active member of the organisation AMEN (Israel). He has graduated in Computer Science from the Technion, Israel Institute of Technology and has a master’s in MBA with distinction from Derby University. He is a Software engineer with 25 years of experience in the fields of development, marketing, and program management in various hi-tech companies. For the last ten years, Zvi has worked for Intel Israel. He aims to improve early diagnosis of myeloma. In addition, he is willing to strengthen patient organisations across Europe by sharing knowledge and information. Zvi completed the MPE Advocate Development Program (ADP) in 2021.
New ways to administer daratumumab and isatuximab get positive recommendations from EMA
At the end of March, the Committee for Medicinal Products for Human Use (CHMP) announced two positive recommendations for new ways of administering the existing myeloma drugs daratumumab and isatuximab.…